tricoderm ointment
winwa medical sdn. bhd. - triamcinolone acetonide; econazole nitrate -
tricoderm cream
general pharmaceuticals ltd. - econazole nitrate + triamcinolone acetonide - cream - 1 gm + 100 mg/100 gm
trichoderma harzianum
agrimm technologies limited - trichoderma harzianum - unknown - trichoderma harzianum biological-organism-fungus active 0.0 - active constituent
triderm cream
organon pharma israel ltd., israel - betamethasone as dipropionate; clotrimazole; gentamicin (as sulfate) - cream - clotrimazole 10 mg/g; betamethasone as dipropionate 0.5 mg/g; gentamicin (as sulfate) 1 mg/g - corticosteroids, potent, other combinations - treatment of corticosteroid-responsive dermatoses when complicated by infections caused by bacteria (sensitive to gentamicin) and fungi (sensitive to clotrimazole) or when the possibility of such infections is suspected. the cream is suitable for the use of oozing eczema.
vinevax biological wound dressing fungicide
agrimm technologies limited - trichoderma harzianum - wettable powder - trichoderma harzianum biological-organism-fungus active 500.0 m cfu/g - fungicide - grapevine - dying arm disease
vinevax bio-injection biological fungicide
agrimm technologies limited - trichoderma harzianum - wettable powder - trichoderma harzianum biological-organism-fungus active 5.0 b cfu/g - fungicide - grapevine - dying arm disease | grapevine dieback fungus
triderm- triamcinolone acetonide cream
crown laboratories - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 5 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hpa axis suppression and cushing’s syndrome than mature patients because of a larger skin surface area to body weight ratio. hypothalamic-pituitary-adrenai (hpa) axis suppression, cushing’s syndrome, and intracranial hypertension have been reported in pediatric patients receiving topical corticosteroids. manifestations of adrenal suppression in pediatric patients include linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to acth stimulation. manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema. administration of topical cortico
triderma- hydroquinone, tretinoin, fluocinolone acetonide cream
pella pharmaceutical co. ltd - tretinoin (unii: 5688utc01r) (tretinoin - unii:5688utc01r), fluocinolone acetonide (unii: 0cd5fd6s2m) (fluocinolone acetonide - unii:0cd5fd6s2m), hydroquinone (unii: xv74c1n1ae) (hydroquinone - unii:xv74c1n1ae) - triderma is indicated for the short-term intermittent treatment of moderate to severe melasma of the face, in the presence of measures for sun avoidance, including the use of sunscreens. triderma is contraindicated in individuals with a history of hypersensitivity, allergy, or intolerance to this product or any of its components.
kiwivax
agrimm technologies ltd - trichoderma atroviride (lu668); trichoderma atroviride (lu297); trichoderma virens (lu753) - trichoderma atroviride (lu668) 800 m cfu/g; trichoderma atroviride (lu297) 800 m cfu/g; trichoderma virens (lu753) 800 m cfu/g - bactericide
vinevax bio-dowel
agrimm technologies ltd - trichoderma atroviride (strains ag1, ag2, ag3, ag5, ag11, ag15) - trichoderma atroviride (strains ag1, ag2, ag3, ag5, ag11, ag15) 100 m units/dowel - fungicide